Article2022
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma
Stamatis Karakatsanis, Maria Bouzani, Argiris Symeonidis, Maria K. Angelopoulou, Sotirios G. Papageorgiou, Michail Michail, Gabriella Gainaru, Georgia Kourti, Sotirios Sachanas, Christina Kalpadakis, Eirini Katodritou, Theoni Leonidopoulou, Ιoannis Kotsianidis, Eleftheria Hatzimichael, Maria Kotsopoulou, Maria Dimou, Eleni Variamis, Dimitrios Boutsis, N. Kanellias, Maria Dimopoulou, Evridiki Michali, George Karianakis, Pantelis Tsirkinidis, ,
Letter2015
PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy
T. P. Vassilakopoulos, G. Pangalis, Sofia Chatziioannou, Sotirios G. Papageorgiou, Maria K. Angelopoulou, Zacharoula Galani, Georgia Kourti, V. Prassopoulos, Theoni Leonidopoulou, Evangelos Terpos, Maria Dimopoulou, Sotirios Sachanas, Christina Kalpadakis, Pavlina Konstantinidou, D. Boutsis, Ekaterini Stefanoudaki, Lydia Kyriazopoulou, Marina P. Siakantaris, M-C Kyrtsonis, Eleni Variami, Ιoannis Kotsianidis,
Discussion(0)
No comments yet. Be the first to comment.